Influence of Luehea divaricata Mart. extracts on peripheral vascular resistance and the role of nitric oxide and both Ca+2-sensitive and Kir6.1 ATP-sensitive K+ channels in the vasodilatory effects of isovitexin on isolated perfused mesenteric beds

Phytomedicine. 2019 Mar 15:56:74-82. doi: 10.1016/j.phymed.2018.08.014. Epub 2018 Aug 11.

Abstract

Background: Luehea divaricata Mart. (Malvaceae) is an important medicinal species widely used by indigenous and riverside populations of the Brazilian Pantanal region. It has been shown that the several extracts obtained from leaves of this species have important cardioprotective effects. Nevertheless, the secondary metabolites responsible for this activity, as well as the molecular mechanisms responsible for their pharmacological effects remain unknown.

Purpose: To carry out a biomonitoring study to identify possible active metabolites present in different ESLD fractions and evaluate the mechanisms responsible for the vasodilatory effects on isolated perfused mesenteric beds.

Methods: First, ESLD was obtained from L. divaricata leaves and a liquid-liquid fractionation was performed. The resulting fractions were analyzed by liquid chromatography-mass spectrometry. Then, the possible vasodilatory effects of ESLD, chloroform, ethyl acetate, n-butanolic and aqueous fractions on perfused arterial mesenteric vascular beds were evaluated. Finally, the molecular mechanisms involved in vasodilator responses of the aqueous fraction and its chemical component, isovitexin, on the mesenteric arteriolar tone were also investigated.

Results: In preparations with functional endothelium ESLD, n-butanolic, aqueous fraction and isovitexin dose-dependently reduced the perfusion pressure in mesenteric vascular beds. Endothelium removal or inhibition of nitric oxide synthase enzymes by L-NAME reduced the vasodilatory effects induced by aqueous fraction and isovitexin. Perfusion with nutritive solution containing 40 mM KCl abolished the vasodilatory effect of all aqueous fractions and Isovitexin doses. Treatment with glibenclamide, a Kir6.1 (ATP-sensitive) potassium channels blocker, tetraethylammonium, a non-selective KCa (calcium-activated) potassium channels blocker, or apamin, a potent blocker of small conductance Ca2+-activated (SK KCa) potassium channels reduced by around 70% vasodilation induced by all aqueous fractions and isovitexin doses. In addition, association of tetraethylammonium and glibenclamide, or L-NAME and glibenclamide, fully inhibited aqueous fraction and Isovitexin -induced vasodilation.

Conclusion: This study showed that AqueFr obtained from Luehea divaricata and its metabolite - isovitexin - has important vasodilatory effects on MVBs. Apparently, these effects are dependent on endothelium-NO release and both SK KCa K+ channels and Kir6.1 ATP-sensitive K+ channels activation in the vascular smooth muscle.

Keywords: Arterial bed; Malvaceae; Nitric oxide; Potassium channels; cGMP.

MeSH terms

  • Animals
  • Apigenin / pharmacology*
  • Brazil
  • Female
  • Glyburide / pharmacology
  • KATP Channels / antagonists & inhibitors
  • KATP Channels / metabolism
  • Malvaceae / chemistry*
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Organ Culture Techniques
  • Plant Extracts / pharmacology*
  • Plants, Medicinal / chemistry
  • Rats, Wistar
  • Vascular Resistance / drug effects*
  • Vasodilation / drug effects
  • Vasodilator Agents / pharmacology*

Substances

  • KATP Channels
  • Plant Extracts
  • Vasodilator Agents
  • uK-ATP-1 potassium channel
  • Nitric Oxide
  • Apigenin
  • Nitric Oxide Synthase
  • isovitexin
  • Glyburide